{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T17:12:04Z","timestamp":1785604324131,"version":"3.56.0"},"reference-count":23,"publisher":"Japan Endocrine Society","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocr J"],"published-print":{"date-parts":[[2021]]},"DOI":"10.1507\/endocrj.ej20-0717","type":"journal-article","created":{"date-parts":[[2021,5,10]],"date-time":"2021-05-10T22:08:16Z","timestamp":1620684496000},"page":"1187-1195","source":"Crossref","is-referenced-by-count":5,"title":["Symptomatic hypocalcemia after treatment for hyperthyroidism in a woman with chromosome 22q11.2 deletion syndrome complicated by Graves\u2019 disease: longitudinal changes in the number of subsets of CD4 and CD8 lymphocytes after thyroidectomy"],"prefix":"10.1507","volume":"68","author":[{"given":"Toshie","family":"Iijima","sequence":"first","affiliation":[{"name":"Department of Endocrinology and Metabolism, Dokkyo Medical University, Tochigi 321-0293, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teruo","family":"Jojima","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Dokkyo Medical University, Tochigi 321-0293, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soichiro","family":"Hosonuma","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Dokkyo Medical University, Tochigi 321-0293, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eriko","family":"Ohhira","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Dokkyo Medical University, Tochigi 321-0293, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuya","family":"Tomaru","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Dokkyo Medical University, Tochigi 321-0293, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiko","family":"Kogai","sequence":"additional","affiliation":[{"name":"Department of Infection Control and Clinical Laboratory Medicine, Dokkyo Medical University, Tochigi 321-0293, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isao","family":"Usui","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Dokkyo Medical University, Tochigi 321-0293, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshimasa","family":"Aso","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Dokkyo Medical University, Tochigi 321-0293, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"386","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1 Kobrynski LJ, Sullivan KE (2007) Velocardiofacial syndrome, DiGeorge syndrome: the chromosome 22q11.2 deletion syndromes. Lancet 370: 1443\u20131452.","DOI":"10.1016\/S0140-6736(07)61601-8"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2 Sullivan KE (2019) Chromosome 22q11.2 deletion syndrome and DiGeorge syndrome. Immunol Rev 287: 186\u2013201.","DOI":"10.1111\/imr.12701"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3 Gennery AR, Barge D, O\u2019Sullivan JJ, Flood TJ, Abinun M, et al. (2002) Antibody deficiency and autoimmunity in 22q11.2 deletion syndrome. Arch Dis Child 86: 422\u2013425.","DOI":"10.1136\/adc.86.6.422"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4 Ferrando-Mart\u00ednez S, Lorente R, Gurbindo D, De Jos\u00e9 MI, Leal M, et al. (2014) Low thymic output, peripheral homeostasis deregulation, and hastened regulatory T cells differentiation in children with 22q11.2 deletion syndrome. J Pediatr 164: 882\u2013889.","DOI":"10.1016\/j.jpeds.2013.12.013"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5 Chang LS, Barroso-Sousa R, Tolaney SM, Hodi FS, Kaiser UB, et al. (2019) Endocrine toxicity of cancer immunotherapy targeting immune checkpoints. Endocr Rev 40: 17\u201365.","DOI":"10.1210\/er.2018-00006"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6 Ueda Y, Uraki S, Inaba H, Nakashima S, Ariyasu H, et al. (2017) Graves\u2019 disease in pediatric and elderly patients with 22q11.2 deletion syndrome. Intern Med 56: 1169\u20131173.","DOI":"10.2169\/internalmedicine.56.7927"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 Kawamura T, Nimura I, Hanafusa M, Fujikawa R, Okubo M, et al. (2000) DiGeorge syndrome with Graves\u2019 disease: a case report. Endocr J 47: 91\u201395.","DOI":"10.1507\/endocrj.47.91"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8 Kawame H, Adachi M, Tachibana K, Kurosawa K, Ito F, et al. (2001) Graves\u2019 disease in patients with 22q11.2 deletion. J Pediatr 139: 892\u2013895.","DOI":"10.1067\/mpd.2001.119448"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9 Ham Pong AJ, Cavallo A, Holman GH, Goldman AS (1985) DiGeorge syndrome: long-term survival complicated by Graves disease. J Pediatr 106: 619\u2013620.","DOI":"10.1016\/S0022-3476(85)80087-1"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10 Meek CL, Kaplan F, Pereira RS, Viljoen A (2011) Hypocalcemia following treatment for hyperthyroidism. Clin Chem 57: 811\u2013814.","DOI":"10.1373\/clinchem.2010.150375"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11 Brown JJ, Datta V, Browning MJ, Swift PG (2004) Graves\u2019 disease in DiGeorge syndrome: patient report with a review of endocrine autoimmunity associated with 22q11.2 deletion. J Pediatr Endocrinol Metab 17: 1575\u20131579.","DOI":"10.1515\/JPEM.2004.17.11.1575"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12 Lima K, Abrahamsen TG, Wolff AB, Husebye E, Alimohammadi M, et al. (2011) Hypoparathyroidism and autoimmunity in the 22q11.2 deletion syndrome. Eur J Endocrinol 165: 345\u2013352.","DOI":"10.1530\/EJE-10-1206"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13 Cancrini C, Puliafito P, Digilio MC, Soresina A, Martino S, et al. (2014) Clinical features and follow-up in patients with 22q11.2 deletion syndrome. J Pediatr 164: 1475\u20131480.e2.","DOI":"10.1016\/j.jpeds.2014.01.056"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14 Sullivan KE, Mcdonald-McGinn D, Zackai EH (2002) CD4+ CD25+ T Cell production in healthy humans and in patients with thymic hypoplasia. Clin Diagn Lab Immunol 9: 1129\u20131131.","DOI":"10.1128\/CDLI.9.5.1129-1131.2002"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15 McLean-Tooke A, Barge D, Spickett GP, Gennery AR (2008) Immunologic defects in 22q11.2 deletion syndrome. J Allergy Clin Immunol 122: 362\u2013367.e4.","DOI":"10.1016\/j.jaci.2008.03.033"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16 Di Cesare S, Puliafito P, Ariganello P, Marcovecchio GE, Mandolesi M, et al. (2015) Autoimmunity and regulatory T cells in 22q11.2 deletion syndrome patients. Pediatr Allergy Immunol 26: 591\u2013594.","DOI":"10.1111\/pai.12420"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17 Mao C, Wang S, Xiao Y, Xu J, Jiang Q, et al. (2011) Impairment of regulatory capacity of CD4+CD25+ regulatory T cells mediated by dendritic cell polarization and hyperthyroidism in Graves\u2019 disease. J Immunol 186: 4734\u20134743.","DOI":"10.4049\/jimmunol.0904135"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18 Klatka M, Grywalska E, Partyka M, Charytanowicz M, Kiszczak-Bochynska M, et al. (2014) Th17 and Treg cells in adolescents with Graves\u2019 disease. Impact of treatment with methimazole on these cell subsets. Autoimmunity 47: 201\u2013211.","DOI":"10.3109\/08916934.2013.879862"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19 Pyzik A, Grywalska E, Matyjaszek-Matuszek B, Smole\u0144 A, Pyzik D, et al. (2017) Frequencies of PD-1- positive T CD3+CD4+, T CD3+CD8+ and B CD19+ lymphocytes in female patients with Graves\u2019 disease and healthy controls- preliminary study. Mol Cell Endocrinol 448: 28\u201333.","DOI":"10.1016\/j.mce.2017.03.006"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20 Bossowski A, Urban M, Stasiak-Barmuta A (2003) Analysis of changes in the percentage of B (CD19) and T (CD3) lymphocytes, subsets CD4, CD8 and their memory (CD45RO), and naive (CD45RA) T cells in children with immune and non-immune thyroid diseases. J Pediatr Endocrinol Metab 16: 63\u201370.","DOI":"10.1515\/JPEM.2003.16.1.63"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21 Baxter JD, Bondy PK (1996) Hypercalcemia of thyrotoxicosis. Ann Intern Med 65: 429\u2013442.","DOI":"10.7326\/0003-4819-65-3-429"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22 Cheung ENM, George SR, Costain GA, Andrade DM, Chow EWC, et al. (2014) Prevalence of hypocalcaemia and its associated features in 22q11\u00b72 deletion syndrome. Clin Endocrinol (Oxf) 81: 190\u2013196.","DOI":"10.1111\/cen.12466"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23 See ACH, Soo KC (1997) Hypocalcaemia following thyroidectomy for thyrotoxicosis. Br J Surg 84: 95\u201397.","DOI":"10.1046\/j.1365-2168.1997.02503.x"}],"container-title":["Endocrine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/68\/10\/68_EJ20-0717\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,30]],"date-time":"2021-10-30T03:39:08Z","timestamp":1635565148000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/68\/10\/68_EJ20-0717\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021]]},"references-count":23,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1507\/endocrj.ej20-0717","relation":{},"ISSN":["0918-8959","1348-4540"],"issn-type":[{"value":"0918-8959","type":"print"},{"value":"1348-4540","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021]]},"article-number":"EJ20-0717"}}